Icon
+91 94997 68112
Login Register

RILUTEK (nda020599)- (50MG)

RILUZOLE COVIS
50MG
No No
2013-Jun-18 Expired
None None
None No
RILUTEK is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
6 0 5
Total Other Developers None
Drugs with Suitability No
50MG ** ** - - 5
NDA Sales Available Total Generic Sales Available
No 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******** ****** *** ******** *************** ******* *********** **** ** *-*, ******* ********** ******, *******-******,, ***, ** ******, ***** (***) ***
****** *** ***** **** *** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** **** **. ***, ******* ****** ***** *****, *******, ******, *****, ***** & *** ******, ***** (***) ***
****** ****** ******** ****. & *****. **., ***. ***** ** *********** **. ***, ******* **., ****** ****, *****, ****** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.